First Allied Advisory Services’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.16M Buy
+4,172
New +$1.2M 0.04% 432
2019
Q3
Sell
-798
Closed -$208K 1694
2019
Q2
$208K Sell
798
-176
-18% -$46.7K 0.01% 1084
2019
Q1
$282K Sell
974
-303
-24% -$101K 0.01% 898
2018
Q4
$418K Buy
1,277
+74
+6% +$25.7K 0.02% 665
2018
Q3
$540K Buy
1,203
+80
+7% +$31.5K 0.02% 694
2018
Q2
$461K Sell
1,123
-659
-37% -$239K 0.02% 707
2018
Q1
$522K Sell
1,782
-131
-7% -$33.2K 0.02% 652
2017
Q4
$356K Buy
1,913
+511
+36% +$95.4K 0.01% 797
2017
Q3
$234K Buy
+1,402
New +$212K 0.01% 932

Other funds holding ABMD

First Allied Advisory Services's ABMD Position: Q3 2020 in Review

First Allied Advisory Services opened a new position in Abiomed Inc (ABMD) in Q3 2020: 4,172 shares worth $1.16M. The stake represents 0.04% of the portfolio and ranks #432 among its holdings. This is a return to the name: First Allied Advisory Services previously reported a position in ABMD as recently as Q2 2019.

First Allied Advisory Services first reported a position in ABMD in Q3 2017 and has held it in 9 quarters since. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • First Allied Advisory Services held 4,172 shares of Abiomed Inc worth $1.16M as of Q3 2020.
  • Abiomed Inc was a new First Allied Advisory Services position in Q3 2020.
  • Abiomed Inc made up 0.04% of First Allied Advisory Services's portfolio in Q3 2020, its #432 holding.
  • First Allied Advisory Services first reported a position in Abiomed Inc in Q3 2017 and has held it in 9 quarters since.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.